Author:
Mondello Patrizia,Mian Michael,Arrigo Carmela,Pitini Vincenzo
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Baar J, Burkes RL, Bell R, Blackstein ME, Fernandes B, Langer F: Primary non-Hodgkin’s lymphoma of bone: a clinicopathological study. Cancer 1994, 73: 1194-1199. 10.1002/1097-0142(19940215)73:4<1194::AID-CNCR2820730412>3.0.CO;2-R
2. Beal K, Allen L, Yahalom J: Primary bone lymphoma: treat- ment results and prognostic factors with long-term follow-up of 82 patients. Cancer 2006, 106(12):2652. e2656 10.1002/cncr.21930
3. Bonnet C, Fillet G, Mounier N, Ganem G, Molina TJ, Thiéblemont C, Fermé C, Quesnel B, Martin C, Gisselbrecht C, Tilly H, Reyes F, Groupe d’Etude des Lymphomes de l’Adulte: CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 2007, 25(7):787-792. 10.1200/JCO.2006.07.0722
4. Bruno Ventre M, Ferreri AJ, Gospodarowicz M, Govi S, Messina C, Porter D, Radford J, Heo DS, Park Y, Martinelli G, Taylor E, Lucraft H, Hong A, Scarfò L, Zucca E, Christie D, International Extranodal Lymphoma Study Group: Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study). Oncologist 2014, 19(3):291-298. 10.1634/theoncologist.2013-0249
5. Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D, Johnson P, Lister A, Feuring-Buske M, Radford JA, Capdeville R, Diehl V, Reyes F: Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998, 92: 1927-1932.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献